Understanding the Conclusions of Taxotere® Clinical Studies

Taxotere® Side Effects

Alopecia, or permanent hair loss, is one of the most troubling complications for Taxotere® patients. Additionally, there have been reports of several other troubling side effects, including:

• Low white blood cell count
• Increased risk of infection
• Numbness in the fingers and toes
• Changes in the color of the fingernails or toenails
• Complete nail loss

If you have been injured by a defective drug, Speak with an Attorney

Clinical Studies on the Effects of Taxotere®

After reports of serious complications associated with Taxotere® began to surface, several clinical studies were conducted to evaluate the safety and efficacy of the drug:

• At the 2014 NCRI Cancer Conference, a study was presented that found as many as 15 percent of Taxotere® patients suffered from pervasive or permanent alopecia. The researchers concluded that health care providers should take these serious side effects into account before choosing to include Taxotere® as part of a patient’s chemotherapy regimen.
• A July 2012 article published in Journal of Clinical Oncology found that newer chemotherapy medications, including Taxotere®, were associated with a higher risk of more severe complications, both during and after treatment. The study found that patients taking these drugs were 40 percent more likely to suffer a fatal complication, while 52 percent were more likely to suffer severe side effects, when compared to patients who were prescribed traditional chemotherapy medications.
• In a May 2012 article published in the Annals of Oncology journal, researchers found that women who were treated for breast cancer with Taxotere® and suffered alopecia were unresponsive to hair regrowth therapies.
• In 2010, the results of a study sponsored by Sanofi in the 1990s were published in The New England Journal of Medicine. The researchers found that almost 10 percent of women who used Taxotere® as part of their chemotherapy regimen suffered from permanent alopecia.
• A 2009 article published in the Journal of American Academy of Dermatology found a significant increase in permanent alopecia among patients who were prescribed high chemotherapy doses of medications such as Taxotere®.

Schedule a Free Case Evaluation

If you or a loved one has suffered a serious complication such as permanent hair loss after being prescribed Taxotere® for chemotherapy, please contact us today to schedule a consultation. We understand the devastating effects these complications can have on your quality of life and a qualified Taxotere® attorney will work diligently to secure compensation.